Stockreport

NewcelX CEO Issues Letter to Shareholders

NewcelX Ltd. - Ordinary Shares  (NCEL) 
PDF ZURICH, Nov. 4, 2025 /PRNewswire/ -- NewcelX Ltd. (Nasdaq: NCEL), a Swiss clinical-stage biopharmaceutical company developing cell-base [Read more]